The Enterprise Value as of November 2024 (TTM) for Harmony Biosciences Holdings, Inc. (HRMY) is 1.74B

According to Harmony Biosciences Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.74B. This represents a change of -3.41% compared to the average of 1.80B of the last 4 quarters.

Harmony Biosciences Holdings, Inc. (HRMY) Historical Enterprise Value (quarterly & annually)

How has HRMY Enterprise Value performed in the past?

The mean historical Enterprise Value of Harmony Biosciences Holdings, Inc. over the last ten years is 2.32B. The current 1.74B Enterprise Value has changed 7.38% with respect to the historical average. Over the past ten years (40 quarters), HRMY's Enterprise Value was at its highest in in the December 2022 quarter at 3.23B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Harmony Biosciences Holdings, Inc. (HRMY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Harmony Biosciences Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Harmony Biosciences Holdings, Inc. (HRMY) Average Enterprise Value

How has HRMY Enterprise Value performed in the past?

The current Enterprise Value of Harmony Biosciences Holdings, Inc. (HRMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Harmony Biosciences Holdings, Inc. (HRMY) Enterprise Value vs. Peers

How is HRMY’s Enterprise Value compared to its peers?

Harmony Biosciences Holdings, Inc.’s Enterprise Value is less than Keros Therapeutics, Inc. (1.75B), less than Janux Therapeutics, Inc. (2.64B), greater than Fennec Pharmaceuticals Inc. (105.60M), less than Edgewise Therapeutics, Inc. (3.01B), greater than Pliant Therapeutics, Inc. (770.48M), greater than Syndax Pharmaceuticals, Inc. (1.24B), less than Revolution Medicines, Inc. (9.43B), greater than Viridian Therapeutics, Inc. (1.42B), greater than Inozyme Pharma, Inc. (202.73M), greater than Ventyx Biosciences, Inc. (80.09M), less than Nuvalent, Inc. (6.38B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than Travere Therapeutics, Inc. (1.95B), less than Structure Therapeutics Inc. (1.75B), greater than Replimune Group, Inc. (984.10M), greater than Nuvectis Pharma, Inc. (81.37M), greater than Lyra Therapeutics, Inc. (23.90M), greater than Kronos Bio, Inc. (5.32M), greater than Gossamer Bio, Inc. (331.04M), less than IDEAYA Biosciences, Inc. (1.93B), less than Protagonist Therapeutics, Inc. (2.65B), less than Verona Pharma plc (2.96B),

Build a custom stock screener for Harmony Biosciences Holdings, Inc. (HRMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harmony Biosciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Harmony Biosciences Holdings, Inc. (HRMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Harmony Biosciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.